STJ  St. Jude Medical Inc.




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

+0.30 (+0.47%)

Growth Price

Overvalued by 38.72%

Stability Price

Overvalued by 68.27%

Company Metrics

  • 21.13 P/E
  • 3.26 P/S
  • 4.46 P/B
  • 3.027 EPS
  • 13.07% Cash ROIC
  • 0.99 Cash Ratio
  • 1.06 / 1.66% Dividend
  • 1.76M Avg. Vol.
  • 18.376B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


St. Jude Medicals CardioMEMS HF System Tests Positive - Nov 19, 2014
St. Jude Medical Inc. (STJ - Analyst Report) has revealed a retrospective data analysis from its CHAMPION trial, conducted to evaluate the safety and efficacy of its CardioMEMS Heart Failure (HF) System on patients with New York Heart Association (NYHA ...
Data Shows the CardioMEMS HF System Significantly Reduced 30-Day Hospital ... - MarketWatch
Stock Insights on St. Jude Medical, Inc. (NYSE:STJ)
Markets Wired - Nov 19, 2014
[BUSINESS WIRE] St. Jude Medical, Inc. (NYSE:STJ) (Trend Analysis) a global medical device company, announced U.S.
Company Updates:St. Jude Medical , Audience Inc - Markets Insider
Post-Earnings Analyst Review - St. Jude Medical
MarketWatch - Oct 22, 2014 has issued free post-earnings analyst review on St. Jude Medical Inc. STJ, -1.08% On October 15, 2014, the company reported its financial results for Q3 FY14 (period ended September 27, 2014).
St. Jude Medical, Inc. (STJ) Announces Quarterly Dividend of $0.27 - sleekmoney
St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force ...
MarketWatch - Oct 27, 2014
ST. PAUL, Minn., Oct 27, 2014 (BUSINESS WIRE) -- St. Jude Medical, Inc. STJ, -1.51% a global medical device company, today announced U.S.
FDA clears St. Jude ablation catheter - Seeking Alpha (registration)
St Jude Medical to expand production, services here
New Straits Times Online - Nov 13, 2014
GEORGE TOWN: St Jude Medical Inc (SJM) is looking to expand its production and services activities in Malaysia by enhancing its product offering and developing a local vendor eco-system.
St. Jude Medical Given Consensus Recommendation of "Buy" by Brokerages ...
Ticker Report - Nov 14, 2014
St. Jude Medical logo Shares of St. Jude Medical (NYSE:STJ) have been given an average rating of “Buy” by the twenty analysts that are currently covering the stock, Analyst Ratings.
St. Jude Medical Earns AA- Credit Rating from Morningstar (STJ) - WKRB News
Company Announcements: St. Jude Medical , Amber Road - Markets Insider
Company Short and Long Range Price Targets: St. Jude Medical , Westar Energy
Markets Insider - 20 hours ago
St. Jude Medical (NYSE:STJ): The mean estimate for the short term price target for St. Jude Medical (NYSE:STJ) stands at $71.82 according to 17 Analysts.
Closing Bell News Buzz: Fortinet Inc. (FTNT), St. Jude Medical Inc. (STJ ...
WallStreet Scope - 11 hours ago
Fortinet Inc. (FTNT) of the Technology sector changed by 1.03% today, a change from open of 1.90% per share with a volume of 1,648,538.
St. Jude Medical Receives Average Recommendation of "Buy" from Brokerages ...
WKRB News - Nov 10, 2014
St. Jude Medical logo St. Jude Medical (NYSE:STJ) has earned a consensus rating of “Buy” from the twenty ratings firms that are presently covering the stock, Stock Ratings News reports.
St. Jude Medical VP Jeff Fecho Sells 500 Shares (STJ)
Ticker Report - Oct 30, 2014
St. Jude Medical logo St. Jude Medical (NYSE:STJ) VP Jeff Fecho unloaded 500 shares of St. Jude Medical stock on the open market in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $60.55, for a total value ...
St. Jude Medical's "Buy" Rating Reaffirmed at Stifel Nicolaus (STJ) - Watch List News (press release)